Yasuko Terao

Head, External Scientific Engagement, R&D Global Regions Japan
Takeda Pharmaceutical Company Limited
​​Company Website：https://www.takeda.com/

She started her career as a researcher in genome-based drug discovery field and then committed to CNS drug discovery in Takeda Research organization and lead preclinical programs. She moved to Janssen in 2014, where she led therapeutic area strategy planning and portfolio management for R&D in Japan. She also led Real World Evidence (RWE) generation, digital health, translational medicine and external collaborations. Since 2020, she served as Director/the APAC Lead of Global Government Grant Office in Janssen Global R&D. She came back to Takeda and has served as the Head of External Scientific Engagement since September 2023. She received the Master's degree at Kyoto University Graduate School and received her PhD in Pharmacology from Kyushu University in 2009.

Speech title & Synopsis

Takeda R&D ~Our Footprint and Future 

Takeda Pharmaceutical Company Ltd., a global pharmaceutical company, has a distinguished history, originated in Japan since 1781. Over 243 years, we grow our passion and pursuit of life-transforming treatments for patients. Creating better health for people and a brighter future for the world is our purpose. The science and technology we advance are constantly evolving. But through our enduring values, our ambition remains steadfast. We strive to deliver truly transformative treatments, contributing significant value to society while creating an exceptional experience for our people.
We are fostering a vigorous biopharma/entrepreneurial ecosystem in Japan, not only by leveraging our presence in Boston globally, but by making various types of investments in Japan specifically. We have transformed Shonan Research Center to Shonan Health Innovation Park (iPark), an incubation facility to enhance science and innovation, bringing together startup companies, academia, and other industries to create high-impact healthcare solutions from cutting-edge science. In this honorable session, we will share with the audience our footprint in innovation field in Japan/Asia highlighting our achievement in/around iPARK.

​

 

​